MedPlus Health Services Reports Q1 FY27 Results: Revenue Up 21.8% YoY to ₹1,879.60 Crore; Net Profit Stands at ₹33.17 Crore

MedPlus Health Services Limited has declared its unaudited consolidated financial results for the first quarter ended June 30, 2026 (Q1 FY27). The omnichannel retail pharmacy and diagnostics major registered a 21.8% year-on-year increase in operational revenue, backed by robust growth in its core retail segment and continued scaling of its diagnostic services.

Key Financial Highlights for Q1 FY27

(All financial figures in ₹ millions, unless otherwise specified)

Revenue from Operations: Rose 21.8% year-on-year to ₹18,796.00 million (₹1,879.60 crore) in Q1 FY27, up from ₹15,426.34 million in Q1 FY26 and ₹18,643.85 million in Q4 FY26.

Total Income: Advanced to ₹18,994.26 million (₹1,899.43 crore), inclusive of ₹198.26 million in other income, compared to ₹15,576.53 million in Q1 FY26.

Profit Before Tax (PBT): Reported at ₹418.77 million (₹41.88 crore) for Q1 FY27, compared to ₹527.66 million in Q1 FY26 and ₹803.42 million in Q4 FY26.

Net Profit After Tax (PAT): Stood at ₹331.67 million (₹33.17 crore) for the quarter (attributable to shareholders at ₹331.76 million), compared to ₹423.43 million in Q1 FY26.

Total Comprehensive Income: Stood at ₹331.67 million for the period.

Earnings Per Share (EPS): Basic and diluted EPS for the quarter stood at ₹2.76 per equity share (face value of ₹2/- each, not annualized), compared to ₹3.54 in Q1 FY26.

Segmental Performance Breakdown

MedPlus's operational revenue and segment profitability for Q1 FY27:

1. Revenue by Division

Retail Operations: Revenue expanded 21.8% Y-o-Y to ₹18,423.92 million (₹1,842.39 crore), accounting for 98.0% of total revenue from operations.

Diagnostic Services: Revenue grew 22.4% Y-o-Y to ₹370.76 million (vs. ₹302.90 million in Q1 FY26).

Others: Contributed ₹1.32 million during the quarter.

2. Segment Results (Profitability)

Retail Segment Profit: Stood at ₹315.63 million compared to ₹449.54 million in Q1 FY26 and ₹705.23 million in Q4 FY26.

Diagnostic Services Segment Profit: Expanded significantly to ₹23.24 million, up from ₹0.77 million in Q1 FY26 and ₹9.64 million in Q4 FY26.

Unallocable Other Income (Net): Contributed ₹80.29 million to the total profit before tax.

Expense Analysis

Consolidated total expenses for Q1 FY27 were reported at ₹18,575.49 million, compared to ₹15,048.87 million in Q1 FY26:

Purchases of Stock-in-Trade: Stood at ₹14,590.48 million (vs. ₹10,529.48 million in Q1 FY26).

Changes in Inventories: Recorded a credit/buildup of ₹(604.23) million (vs. ₹676.08 million in Q1 FY26).

Employee Benefits Expense: Accounted for ₹2,419.06 million (vs. ₹2,004.41 million in Q1 FY26).

Other Expenses: Stood at ₹851.63 million (vs. ₹717.27 million in Q1 FY26).

Depreciation & Amortization: Increased to ₹779.21 million (vs. ₹656.18 million in Q1 FY26).

Finance Costs: Stood at ₹332.70 million (vs. ₹273.65 million in Q1 FY26).

Cost of Materials Consumed: Accounted for ₹206.64 million.

Total Tax Expenses: Stood at ₹87.10 million (comprising current tax of ₹114.87 million offset by deferred tax benefit of ₹27.77 million).

Balance Sheet Position & Asset Distribution

Total Assets: Stood at ₹40,431.00 million as of June 30, 2026, compared to ₹39,325.26 million as of March 31, 2026.

Retail Assets: Accounted for ₹31,919.79 million.

Diagnostic Assets: Accounted for ₹1,380.92 million.

Unallocated Assets: Stood at ₹7,126.66 million.

Total Liabilities: Stood at ₹20,324.09 million (Retail: ₹19,247.99 million; Diagnostics: ₹1,074.70 million).

Paid-Up Equity Share Capital: Reported at ₹240.27 million (face value ₹2 per share).

Other Equity: Stood at ₹19,513.48 million as of March 31, 2026.

Shares of Medplus Health Services Limited was last trading in BSE at Rs. 795.40 as compared to the previous close of Rs. 800.95. The total number of shares traded during the day was 5046 in over 586 trades.

The stock hit an intraday high of Rs. 808.70 and intraday low of 776.00. The net turnover during the day was Rs. 3993733.00.

Source : Equity Bulls

Keywords

MedplusHealthServices INE804L01022 Pharmacy DiagnosticCentre Q1FY27 Q1FY2027 ResultUpdate